No black box warning on record for Crcle Guaifenesin Extended-Release Tablets, 600 Mg

As of the latest FDA labeling reviewed, Crcle Guaifenesin Extended-Release Tablets, 600 Mg (GUAIFENESIN EXTENDED-RELEASE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Crcle Guaifenesin Extended-Release Tablets, 600 Mg medicine page for the complete safety profile.

Other warnings & precautions

Warnings Do not use for children under 12 years of age Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

No black box warning on record for Crcle Guaifenesin Extended-Release Tablets, 600 Mg

Other warnings & precautions

Warnings Do not use for children under 12 years of age Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

Crcle Guaifenesin Extended-Release Tablets, 600 Mg Black Box Warning

No black box warning on record for Crcle Guaifenesin Extended-Release Tablets, 600 Mg

Other warnings & precautions

Crcle Guaifenesin Extended-Release Tablets, 600 Mg Black Box Warning

No black box warning on record for Crcle Guaifenesin Extended-Release Tablets, 600 Mg

Other warnings & precautions